Nuplazid 34 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FQWNK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,459
Award facts
- Contract value 100% obligated
- $3,458.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency valued at $3,458.51 for 30 capsules of NUPLAZID 34 mg. The award, issued on June 20, 2025, with an ultimate completion date of July 14, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies.
The Defense Logistics Agency utilizes this IDC to source branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support military health facilities nationwide. NUPLAZID, an antipsychotic medication, represents one of the specialized pharmaceutical products within the contract's extensive portfolio. DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain through consistent contract performance with the Defense Logistics Agency, leveraging its woman-owned small business status to compete effectively in federal procurement markets while providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FQWNK?
SPE2DB25FQWNK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 20, 2025.
How much is contract SPE2DB25FQWNK worth?
The government has obligated $3,459 on SPE2DB25FQWNK.
Is contract SPE2DB25FQWNK an order under another contract?
Yes. SPE2DB25FQWNK is a delivery order under SPE2DB25D9321, an indefinite delivery contract.
Was contract SPE2DB25FQWNK competed?
The extent of competition for SPE2DB25FQWNK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award